← Back to all trials
Completed
NCT07302815
Preemptive Intravenous Micro-dose Dexmedetomidine to Prevent Emergence Agitation in Adult Patients Undergoing Septoplasty Surgeries
Conditions: Emergence Agitation
Sex: All
Ages: 18 Years – 60 Years
Healthy volunteers: No
Phase: NA
Enrollment: 120
Sponsor: Tanta University
Location: Tanta university Tanta Gharbia Governorate
Summary
This prospective randomized controlled study will be conducted to evaluate the effect of preoperative single, micro-dose of dexmedetomidine (0.3μg/kg) on the incidence and severity of EA in adults undergoing Septoplasty surgeries
Eligibility Criteria
Inclusion Criteria:
* Adult patients of both gender aged 18 to 60 years with American Society of Anesthesiologists (ASA) Physical Status I or II, who were scheduled for septoplasty surgery under general anesthesia.
Exclusion Criteria:
* Patients declined to participate in the trial.
* History or clinical evidence of chronic obstructive pulmonary disease.
* History of renal or hepatic dysfunction, sleep apnea syndrome.
* Cognitive dysfunction or psychiatric disorder.
* Patients receiving beta blocker.
* Patients with anticipated difficult airway.
* Patients with electro cardiac abnormalities.
* Emergency surgeries.
* Pregnancy.
Source: ClinicalTrials.gov (NCT07302815). StuddyBuddy aggregates publicly available trial information.
